Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio

Jurjen Versluis; F t Hout; RMH (Raynier) Devillier; WLJ van Putten; MG Manz; MC Vekemans; MC Legdeur; JR Passweg; J Maertens; J Kuball; BJ Biemond; Peter Valk; BA van der Reijden; G Meloni; HC Schouten; E Vellenga; T Pabst; R Willemze; Bob Löwenberg; G Ossenkoppele; F Baron; G Huls; Jan Cornelissen

doi:10.1038/leu.2016.183

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio

Jurjen Versluis
, F t Hout
, RMH (Raynier) Devillier
, WLJ van Putten
, MG Manz
, MC Vekemans
, MC Legdeur
, JR Passweg
, J Maertens
, J Kuball
, BJ Biemond
, Peter Valk
, BA van der Reijden
, G Meloni
, HC Schouten
, E Vellenga
, T Pabst
, R Willemze
, Bob Löwenberg
, G Ossenkoppele

F Baron, G Huls, Jan Cornelissen

Hematology

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

62 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	26-33
Number of pages	8
Journal	Leukemia
Volume	31
Issue number	1
DOIs	https://doi.org/10.1038/leu.2016.183
Publication status	Published - 2017

Research programs

EMC MM-02-41-03

Access to Document

10.1038/leu.2016.183

http://hdl.handle.net/1765/108453

Cite this

Versluis, J., t Hout, F., Devillier, RMH., van Putten, WLJ., Manz, MG., Vekemans, MC., Legdeur, MC., Passweg, JR., Maertens, J., Kuball, J., Biemond, BJ., Valk, P., van der Reijden, BA., Meloni, G., Schouten, HC., Vellenga, E., Pabst, T., Willemze, R., Löwenberg, B., ... Cornelissen, J. (2017). Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. Leukemia, 31(1), 26-33. https://doi.org/10.1038/leu.2016.183

@article{0bacd48b6e3f4f7d9984cbca06785593,

title = "Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio",

author = "Jurjen Versluis and \{t Hout\}, F and Devillier, \{RMH (Raynier)\} and \{van Putten\}, WLJ and MG Manz and MC Vekemans and MC Legdeur and JR Passweg and J Maertens and J Kuball and BJ Biemond and Peter Valk and \{van der Reijden\}, BA and G Meloni and HC Schouten and E Vellenga and T Pabst and R Willemze and Bob L{\"o}wenberg and G Ossenkoppele and F Baron and G Huls and Jan Cornelissen",

year = "2017",

doi = "10.1038/leu.2016.183",

language = "Undefined/Unknown",

volume = "31",

pages = "26--33",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "1",

}

Versluis, J, t Hout, F, Devillier, RMH, van Putten, WLJ, Manz, MG, Vekemans, MC, Legdeur, MC, Passweg, JR, Maertens, J, Kuball, J, Biemond, BJ, Valk, P, van der Reijden, BA, Meloni, G, Schouten, HC, Vellenga, E, Pabst, T, Willemze, R, Löwenberg, B, Ossenkoppele, G, Baron, F, Huls, G & Cornelissen, J 2017, 'Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio', Leukemia, vol. 31, no. 1, pp. 26-33. https://doi.org/10.1038/leu.2016.183

TY - JOUR

T1 - Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio

AU - Versluis, Jurjen

AU - t Hout, F

AU - Devillier, RMH (Raynier)

AU - van Putten, WLJ

AU - Manz, MG

AU - Vekemans, MC

AU - Legdeur, MC

AU - Passweg, JR

AU - Maertens, J

AU - Kuball, J

AU - Biemond, BJ

AU - Valk, Peter

AU - van der Reijden, BA

AU - Meloni, G

AU - Schouten, HC

AU - Vellenga, E

AU - Pabst, T

AU - Willemze, R

AU - Löwenberg, Bob

AU - Ossenkoppele, G

AU - Baron, F

AU - Huls, G

AU - Cornelissen, Jan

PY - 2017

Y1 - 2017

U2 - 10.1038/leu.2016.183

DO - 10.1038/leu.2016.183

M3 - Article

C2 - 27416910

SN - 0887-6924

VL - 31

SP - 26

EP - 33

JO - Leukemia

JF - Leukemia

IS - 1

ER -